Senior Manager, Regulatory Intelligence
Regeneron Pharmaceuticals
Summary
At Regeneron, we use science and innovation to develop life-changing medicines for people with serious diseases. We are seeking a Senior Manager Regulatory Intelligence Clinical Development to join our Regulatory Intelligence function, supporting global clinical development in a hybrid work model. In this role, you will provide regulatory intelligence insights, assess evolving global requirements, and support regulatory strategy while collaborating with cross-functional stakeholders.
Job description
Discover your role
- Conduct in-depth regulatory intelligence research and policy analysis.
- Monitor global regulations, guidance, and industry developments impacting drug development.
- Maintain the regulatory intelligence platform for stakeholder communication.
- Assess regulatory changes for impact on processes, projects, and regulatory strategies.
- Identify business-critical regulatory updates and communicate findings to stakeholders.
- Facilitate review of draft guidance comment opportunities and support submissions.
- Support GxP compliance initiatives through cross-functional organizational projects.
- Build strong partnerships while promoting regulatory intelligence awareness and education.
This role requires
- Minimum 8 years of experience in the biotechnology, pharmaceutical, or health authority environment.
- Experience focused on clinical development and regulatory activities.
- Strong understanding of the drug development lifecycle and EU and US regulatory processes.
- Experience monitoring regulatory requirements and sourcing information from FDA, EMA, and similar authority platforms.
- Ability to interpret regulatory guidelines, requirements, and policy documents.
- Expertise researching, analyzing, and translating regulatory intelligence into actionable insights.
- Experience with regulatory intelligence databases and understanding of artificial intelligence applications.
- Ability to manage newsletters, digests, and regulatory information distribution.
- Strong organizational skills with the ability to work independently and meet deliverables.
- Effective written and verbal communication skills, attention to detail, and collaborative relationship-building abilities.
Requirements
- Minimum 8 years of experience in the biotechnology, pharmaceutical, or health authority environment
- Experience focused on clinical development and regulatory activities
- Strong understanding of the drug development lifecycle and EU and US regulatory processes
- Experience monitoring regulatory requirements and sourcing information from FDA, EMA, and similar authority platforms
- Ability to interpret regulatory guidelines, requirements, and policy documents
- Expertise researching, analyzing, and translating regulatory intelligence into actionable insights
- Experience with regulatory intelligence databases and understanding of artificial intelligence applications
- Ability to manage newsletters, digests, and regulatory information distribution
- Strong organizational skills with the ability to work independently and meet deliverables
- Effective written and verbal communication skills, attention to detail, and collaborative relationship-building abilities
Benefits
- Annual bonuses
- Incentive plans
- Equity awards
- Pension or retirement benefits
- 401(k) company match
- Health and wellness programs
- Fitness centers
- Insurance benefits
- Paid time off
- Family support benefits
Company overview
Regeneron Pharmaceuticals is a leading American biotechnology company founded in 1988 and headquartered in Tarrytown, New York. The company specializes in inventing, developing, and commercializing life-transforming medicines for people with serious diseases. Regeneron is renowned for its innovative antibody technologies and has developed several groundbreaking therapies, including EYLEA® for retinal diseases, DUPIXENT® for inflammatory conditions, and the COVID-19 antibody cocktail REGEN-COV®. The company operates with a strong focus on research and development across multiple therapeutic areas including ophthalmology, oncology, cardiovascular diseases, and rare genetic disorders. Regeneron's proprietary VelocImmune® technology platform enables the rapid generation of fully human monoclonal antibodies. With over 15,000 employees globally and annual revenues exceeding $14 billion, Regeneron has established itself as a major force in the biotechnology industry, consistently ranking among the top-performing pharmaceutical companies and maintaining a robust pipeline of investigational therapies.